Stocks and Investing
Stocks and Investing
Fri, June 30, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, June 29, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mitchell Kapoor Reiterated (carm) at Strong Buy and Held Target at $10 on, Jun 29th, 2023
Mitchell Kapoor of HC Wainwright & Co., Reiterated "Carisma Therapeutics, Inc." (CARM) at Strong Buy and Held Target at $10 on, Jun 29th, 2023.
Mitchell has made no other calls on CARM in the last 4 months.
There is 1 other peer that has a rating on CARM. Out of the 1 peers that are also analyzing CARM, 0 agree with Mitchell's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mitchell
- Jack Allen of "Baird" Reiterated at Buy and Held Target at $10 on, Wednesday, June 28th, 2023
Contributing Sources